As Covid-19 figures continue to rise daily, there is mounting pressure on insurance companies to cover treatment costs. How will this pan out eventually?
THE winners and losers of the Covid-19 pandemic are rather clear. Rubber glove makers dominated the top of the profit hierarchy, followed by tech companies, electronic manufacturing services (EMS) companies and those in the stockbroking business.
Somewhere along that line, there is an industry that has been scooping up profits on the sidelines. Enter the insurance sector.